Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica
Background Cutaneous leishmaniasis (CL) is endemic in Israel, and in the past, has been
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
[PDF][PDF] Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica
M Solomon, F Pavlotsky, E Leshem, M Ephros, H Trau… - academia.edu
Background Cutaneous leishmaniasis (CL) is endemic in Israel, and in the past, has been
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
M Solomon, F Pavlotsky, E Leshem… - Journal of the …, 2010 - europepmc.org
Background Cutaneous leishmaniasis (CL) is endemic in Israel, and in the past, has been
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica
M Solomon, F Pavlotsky, E Leshem, M Ephros… - Journal of the European …, 2011 - infona.pl
Background Cutaneous leishmaniasis (CL) is endemic in Israel, and in the past, has been
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
M Solomon, F Pavlotsky, E Leshem… - Journal of the …, 2011 - search.ebscohost.com
Background Cutaneous leishmaniasis (CL) is endemic in Israel, and in the past, has been
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica
M Solomon, F Pavlotsky, E Leshem… - Journal of the …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Cutaneous leishmaniasis (CL) is endemic in Israel, and in the past, has been
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
M Solomon, F Pavlotsky, E Leshem, M Ephros, H Trau… - 2011 - cabidigitallibrary.org
Background: Cutaneous leishmaniasis (CL) is endemic in Israel, and in the past, has been
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …
attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in …